Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what discussions he had with his Cabinet colleagues on the potential effect on cancer patients of the Government's decision to leave Euratom, before that decision was announced.

Medical radio-isotopes, used in the treatment of some cancers, are not subject to Euratom Supply Agency contracts or to Euratom safeguards. Therefore the United Kingdom’s ability to import medical isotopes from Europe and the rest of the world, and cancer patients’ treatment, will not be affected by withdrawing from Euratom.